Rheumatoid arthritis gene therapy (University of Pittsburgh)

N/A

Report date: 2022/02/17 17:05:09

Base Information

Drug NameRheumatoid arthritis gene therapy (University of Pittsburgh)
Drug Alias NameIL-1Ra gene therapy
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pittsburgh School Of Medicine
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A